Loading...
Cann American Corp.
CNNA•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.004
$0.00(0.00%)
Cann American Corp. (CNNA) Stock Overview
Explore Cann American Corp.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for CNNAStats details for CNNA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CNNAAnalyst Recommendations details for CNNA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.
CEO
Mr. Jason R. Tucker
Employees
1
Headquarters
320 Santana Drive, Cloverdale, CA
Founded
2011